Abstract
Study objectives were to determine, in children with systemic lupus erythematosus (SLE), (1) the association of antiphosholipid antibody (APLA) subtypes with thrombotic events (TEs) and (2) the predictive value of persistent versus transient antibodies for TEs. This is a cohort study of 58 SLE children in whom lupus anticoagulants (LAs), anticardiolipin antibodies (ACLAs), anti–β2-glycoprotein-I (anti–β2-GPI), and antiprothrombin (anti-PT) were assessed on at least 2 occasions (more than 3 months apart). Antibodies were classified as persistent (positive on at least 2 occasions) or transient (positive once). Outcomes were symptomatic TEs confirmed by objective radiographic tests identified retrospectively and prospectively. Seven of the 58 patients (12%) had 10 TEs; 5 patients had TEs during prospective follow-up. Persistent LAs showed the strongest association with TEs (P < .001). Persistent ACLAs (P = .003) and anti–β2-GPI (P = .002) were significantly associated with TEs; anti-PT (P = .063) showed a trend. Persistent or transient LAs and anti–β2-GPI showed similar strength of association, while ACLAs and anti-PT were no longer associated with TEs. Positivity for multiple APLA subtypes showed stronger associations with TEs than for individual APLA subtypes because of improved specificity. Lupus anticoagulant is the strongest predictor of the risk of TEs; other APLA subtypes provide no additional diagnostic value. Anticardiolipin antibodies and anti-PT require serial testing because only persistent antibodies are associated with TEs.
Keywords
MedicineAntiphospholipid syndromePredictive valueImmunologyLupus anticoagulantAntibodyCatastrophic antiphospholipid syndromeInternal medicineGastroenterology
Affiliated Institutions
Related Publications
Prevalence and clinical significance of anticardiolipin and anti‐β2‐glycoprotein‐I antibodies in patients with non‐Hodgkin's lymphoma
Abstract: The association of antiphospholipid antibodies (APA) has been reported in several cases of patients with non‐Hodgkin's lymphoma (NHL) with or without thromboembolic co...
Do antibodies to β2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?
The aim of this study was to determine if the measurement of anti-β2-glycoprotein I antibodies (aβ2-GPI) in serum levels contributes to the better characterization of the clinic...
The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus
Abstract Objective To determine whether antiphospholipid antibodies (aPL) occur before the diagnosis of systemic lupus erythematosus (SLE) and before initial clotting events, an...
Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies
Summary Asymptomatic antiphospholipid antibody (aPL) carriers with high risk for thrombosis may benefit from preventive anticoagulation. It was our objective to test whether the...
Clinical Significance of Anticardiolipin and Anti-β<sub>2</sub>-Glycoprotein I Antibodies
<i>Background:</i> Anticardiolipin (aCl) and anti-β<sub>2</sub>-glycoprotein I (anti-β<sub>2</sub>-gpI) antibodies are autoantibodies associa...
Publication Info
- Year
- 2005
- Type
- article
- Volume
- 106
- Issue
- 13
- Pages
- 4152-4158
- Citations
- 105
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
105
OpenAlex
Cite This
Christoph Male,
D Foulon,
H Hoogendoorn
et al.
(2005).
Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus.
Blood
, 106
(13)
, 4152-4158.
https://doi.org/10.1182/blood-2005-05-2048
Identifiers
- DOI
- 10.1182/blood-2005-05-2048